The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease
Open accessAbstract
The metabolic syndrome is a constellation of metabolic disorders including obesity, hypertension, and insulin resistance, components which are risk factors for the development of diabetes, hypertension, cardiovascular, and renal disease. Pathophysiological abnormalities that contribute to the development of the metabolic syndrome include impaired mitochondrial oxidative phosphorylation and mitochondrial biogenesis, dampened insulin metabolic signaling, endothelial dysfunction, and associated myocardial functional abnormalities. Recent evidence suggests that impaired myocardial mitochondrial biogenesis, fatty acid metabolism, and antioxidant defense mechanisms lead to diminished cardiac substrate flexibility, decreased cardiac energetic efficiency, and diastolic dysfunction. In addition, enhanced activation of the renin–angiotensin–aldosterone system and associated increases in oxidative stress can lead to mitochondrial apoptosis and degradation, altered bioenergetics, and accumulation of lipids in the heart. In addition to impairments in metabolic signaling and oxidative stress, genetic and environmental factors, aging, and hyperglycemia all contribute to reduced mitochondrial biogenesis and mitochondrial dysfunction. These mitochondrial abnormalities can predispose a metabolic cardiomyopathy characterized by diastolic dysfunction. Mitochondrial dysfunction and resulting lipid accumulation in skeletal muscle, liver, and pancreas also impede insulin metabolic signaling and glucose metabolism, ultimately leading to a further increase in mitochondrial dysfunction. Interventions to improve mitochondrial function have been shown to correct insulin metabolic signaling and other metabolic and cardiovascular abnormalities. This review explores mechanisms of mitochondrial dysfunction with a focus on impaired oxidative phosphorylation and mitochondrial biogenesis in the pathophysiology of metabolic heart disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Oxidative damage and mitochondrial decay in aging.
Shigenaga, M. K., Hagen, T. M., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10771 · Cited by 2,055 · cited 2×
“In particular, mitochondrial generation of excess ROS contributes to protein, DNA, and lipid injury and, ultimately, reductions in mitochondrial biogenesis and mitochondrial dysfunction [7, 56].”
BackgroundPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Diabetic Cardiomyopathy Revisited
Boudina, S., & Abel, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.679597 · Cited by 1,543
Yu, T., Robotham, J. L., & Yoon, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511154103 · Cited by 1,246
Role of Mitochondrial Dysfunction in Insulin Resistance
Kim, J.-A., Wei, Y., & Sowers, J. R. (2008) · Circulation Research · doi:10.1161/circresaha.107.165472 · Cited by 1,103
Self-citationThe role of exercise and PGC1α in inflammation and chronic disease
Handschin, C., & Spiegelman, B. M. (2008) · Nature · doi:10.1038/nature07206 · Cited by 1,083
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887
Morino, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25151 · Cited by 811
Bassuk, S. S., & Manson, J. E. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00160.2005 · Cited by 744
Doughan, A. K., Harrison, D. G., & Dikalov, S. I. (2008) · Circulation Research · doi:10.1161/circresaha.107.162800 · Cited by 710
Arany, Z., He, H., Lin, J., Hoyer, K., Handschin, C., Toka, O., Ahmad, F., Matsui, T., Chin, S., Wu, P.-H., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.03.002 · Cited by 694
Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis
Bergeron, R., Ren, J. M., Cadman, K. S., Moore, I. K., Perret, P., Pypaert, M., Young, L. H., Semenkovich, C. F., & Shulman, G. I. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1340 · Cited by 561
Self-citationSt-Pierre, J., Lin, J., Krauss, S., Tarr, P. T., Yang, R., Newgard, C. B., & Spiegelman, B. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301850200 · Cited by 542
Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle
Boushel, R., Gnaiger, E., Schjerling, P., Skovbro, M., Kraunsøe, R., & Dela, F. (2007) · Diabetologia · doi:10.1007/s00125-007-0594-3 · Cited by 519
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals
Nisoli, E., Falcone, S., Tonello, C., Cozzi, V., Palomba, L., Fiorani, M., Pisconti, A., Brunelli, S., Cardile, A., Francolini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405432101 · Cited by 495
Mitochondrial reactive oxygen species-mediated signaling in endothelial cells
Zhang, D. X., & Gutterman, D. D. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01283.2006 · Cited by 439
Czubryt, M. P., McAnally, J., Fishman, G. I., & Olson, E. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337639100 · Cited by 418
Endothelial Mitochondria: Contributing to Vascular Function and Disease
Davidson, S. M., & Duchen, M. R. (2007) · Circulation Research · doi:10.1161/01.res.0000261970.18328.1d · Cited by 381
The role of AMP‐activated protein kinase in mitochondrial biogenesis
Reznick, R. M., & Shulman, G. I. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.109512 · Cited by 373
Sowers, J. R., Whaley-Connell, A., & Epstein, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00005 · Cited by 351
Self-citationMultiple Risk Factors for Cardiovascular Disease and Diabetes Mellitus
Smith, S. C. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.01.002 · Cited by 325
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Cooper, S. A., Whaley-Connell, A., Habibi, J., Wei, Y., Lastra, G., Manrique, C., Stas, S., & Sowers, J. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00522.2007 · Cited by 317
Self-citationLing, C., Poulsen, P., Carlsson, E., Ridderstråle, M., Almgren, P., Wojtaszewski, J., Beck-Nielsen, H., Groop, L., & Vaag, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21889 · Cited by 300
Finck, B. N., & Kelly, D. P. (2007) · Circulation · doi:10.1161/circulationaha.107.670588 · Cited by 282
Mechanisms of [Ca2+]i Transient Decrease in Cardiomyopathy of db/db Type 2 Diabetic Mice
Pereira, L., Matthes, J., Schuster, I., Valdivia, H. H., Herzig, S., Richard, S., & Gómez, A. M. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1284 · Cited by 256
Defective intracellular Ca2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats
Choi, K. M., Zhong, Y., Hoit, B. D., Grupp, I. L., Hahn, H., Dilly, K. W., Guatimosim, S., Lederer, W. J., & Matlib, M. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00313.2002 · Cited by 251
Igata, M., Motoshima, H., Tsuruzoe, K., Kojima, K., Matsumura, T., Kondo, T., Taguchi, T., Nakamaru, K., Yano, M., Kukidome, D., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000185823.73556.06 · Cited by 245
Nisoli, E., Clementi, E., Carruba, M. O., & Moncada, S. (2007) · Circulation Research · doi:10.1161/01.res.0000259591.97107.6c · Cited by 227
Makino, A., Scott, B. T., & Dillmann, W. H. (2010) · Diabetologia · doi:10.1007/s00125-010-1770-4 · Cited by 223
Privratsky, J. R., Wold, L. E., Sowers, J. R., Quinn, M. T., & Ren, J. (2003) · Hypertension · doi:10.1161/01.hyp.0000082814.62655.85 · Cited by 222
Self-citationDuncan, J. G., Fong, J. L., Medeiros, D. M., Finck, B. N., & Kelly, D. P. (2007) · Circulation · doi:10.1161/circulationaha.106.662296 · Cited by 215
PGC-1α and ERRα target gene downregulation is a signature of the failing human heart
Sihag, S., Cresci, S., Li, A. Y., Sucharov, C. C., & Lehman, J. J. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.025 · Cited by 214
Induction of Mitochondrial Biogenesis Is a Maladaptive Mechanism in Mitochondrial Cardiomyopathies
Sebastiani, M., Giordano, C., Nediani, C., Travaglini, C., Borchi, E., Zani, M., Feccia, M., Mancini, M., Petrozza, V., Cossarizza, A., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.035 · Cited by 195
Oxidative stress and stress signaling: menace of diabetic cardiomyopathy
WOLD, L. E., CEYLAN-ISIK, A. F., & REN, J. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00146.x · Cited by 192
Self-citationCapano, M., & Crompton, M. (2006) · Biochemical Journal · doi:10.1042/bj20051654 · Cited by 147
AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction
Turdi, S., Fan, X., Li, J., Zhao, J., Huff, A. F., Du, M., & Ren, J. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00586.x · Cited by 141 · cited 1×
“In contrast, recent findings from our laboratory failed to detect any change in the expression of PGC-1α in myocardium from murine hearts with overexpression of mutant α2 subunit compared with wild-type mice [52].”
ResultSelf-citationMetallothionein Prevents High-Fat Diet–Induced Cardiac Contractile Dysfunction
Dong, F., Li, Q., Sreejayan, N., Nunn, J. M., & Ren, J. T. (2007) · Diabetes · doi:10.2337/db06-1596 · Cited by 138
Self-citationTreatment of overweight and obesity: Lifestyle, pharmacologic, and surgical options
Cannon, C. P., & Kumar, A. (2009) · Clinical cornerstone · doi:10.1016/s1098-3597(09)80005-7 · Cited by 134
de Cavanagh, E. M. V., Toblli, J. E., Ferder, L., Piotrkowski, B., Stella, I., & Inserra, F. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00615.2005 · Cited by 124
Dual Mechanisms Regulating AMPK Kinase Action in the Ischemic Heart
Baron, S. J., Li, J., Russell, R. R., Neumann, D., Miller, E. J., Tuerk, R. D., Wallimann, T., Hurley, R. L., Witters, L. A., & Young, L. H. (2005) · Circulation Research · doi:10.1161/01.res.0000155723.53868.d2 · Cited by 117
Zhou, X., Ma, L., Habibi, J., Whaley-Connell, A., Hayden, M. R., Tilmon, R. D., Brown, A. N., Kim, J.-A., DeMarco, V. G., & Sowers, J. R. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.145136 · Cited by 116 · cited 1×
“Reduced myocardial mitochondrial antioxidant capacity and impaired mitochondrial biogenesis are crucial in the pathogenesis of metabolic-related myocardial dysfunction [7, 10, 13].”
BackgroundSelf-citationStas, S. N., Whaley‐Connell, A. T., Habibi, J., Appesh, L., Hayden, M. R., Karuparthi, P. R., Qazi, M., Morris, E. M., Cooper, S. A., Link, C. D., et al. (2007) · Endocrinology · doi:10.1210/en.2006-1691 · Cited by 114
Self-citationWilliamson, C. L., Dabkowski, E. R., Baseler, W. A., Croston, T. L., Alway, S. E., & Hollander, J. M. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00668.2009 · Cited by 111
Cardiac Health in Women With Metabolic Syndrome: Clinical Aspects and Pathophysiology
Ren, J. T., & Kelley, R. O. (2009) · Obesity · doi:10.1038/oby.2009.8 · Cited by 110
Self-citationMouse models of mitochondrial dysfunction and heart failure
Russell, L. K., Finck, B. N., & Kelly, D. J. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.10.010 · Cited by 108
Lopaschuk, G. D., & Spafford, M. A. (1989) · Circulation Research · doi:10.1161/01.res.65.2.378 · Cited by 98
Impact of Cardiometabolic Risk Factor Clusters on Health‐related Quality of Life in the U.S.
Sullivan, P. W., Ghushchyan, V. H., Wyatt, H. R., Wu, E. Q., & Hill, J. O. (2007) · Obesity · doi:10.1038/oby.2007.580 · Cited by 93
Metabolic risk factors and renal disease
Sowers, J. R. (2007) · Kidney International · doi:10.1038/sj.ki.5002006 · Cited by 85
Self-citationAngiotensin II Reduces Mitochondrial Content in Skeletal Muscle and Affects Glycemic Control
Mitsuishi, M., Miyashita, K., Muraki, A., & Itoh, H. (2008) · Diabetes · doi:10.2337/db08-0949 · Cited by 79
Triggering Mitochondrial Radical Release: A New Function for NADPH Oxidases
Brandes, R. P. (2005) · Hypertension · doi:10.1161/01.hyp.0000165019.32059.b2 · Cited by 79
Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat
Whaley‐Connell, A. T., Habibi, J., Cooper, S. A., DeMarco, V. G., Hayden, M. R., Stump, C. S., Link, D. C., Ferrario, C. M., & Sowers, J. R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00752.2007 · Cited by 58
Self-citationCeylan‐Isik, A. F., Guo, K. K., Carlson, E. C., Privratsky, J. R., Liao, S.-J., Cai, L. F., Chen, A. F., & Ren, J. T. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.123422 · Cited by 57
Self-citationAltered Calcium Homeostasis Does Not Explain the Contractile Deficit of Diabetic Cardiomyopathy
Zhang, L., Cannell, M. B., Phillips, A. R. J., Cooper, G. J. S., & Ward, M. (2008) · Diabetes · doi:10.2337/db08-0140 · Cited by 56
Hypertension and Insulin Resistance
Whaley‐Connell, A. T., & Sowers, J. R. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.134460 · Cited by 56
Self-citationFlagg, T. P., Cazorla, O., Remedi, M. S., Haim, T. E., Tones, M. A., Bahinski, A., Numann, R. E., Kovács, A. D., Schaffer, J. E., Nichols, C. G., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.186809 · Cited by 54
Wei, Y., Whaley‐Connell, A. T., Habibi, J., Rehmer, J. M., Rehmer, N., Patel, K., Hayden, M., DeMarco, V. G., Ferrario, C. M., Ibdah, J. A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.121954 · Cited by 50
Self-citationRegulation and Role of the Mitochondrial Transcription Factor in the Diabetic Rat Heart
Nishio, Y., Kanazawa, A., Nagai, Y., Inagaki, H., & Kashiwagi, A. (2004) · Springer eBooks · doi:10.1007/978-3-662-41088-2_9 · Cited by 44
Regulation and Role of the Mitochondrial Transcription Factor in the Diabetic Rat Heart
Nishio, Y., Kanazawa, A., Nagai, Y., Inagaki, H., & Kashiwagi, A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1293.009 · Cited by 43
Mitochondrial Thioredoxin: Novel Regulator for NADPH Oxidase and Angiotensin II-Induced Hypertension
Fukai, T. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.134403 · Cited by 19
Cited by
Assessing mitochondrial dysfunction in cells
Brand, M. D., & Nicholls, D. G. (2011) · Biochemical Journal · doi:10.1042/bj20110162 · Cited by 2,405
Bhatti, J. S., Bhatti, G. K., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.010 · Cited by 1,655
van der Veen, J. N., Kennelly, J. P., Wan, S., Vance, J. E., Vance, D. E., & Jacobs, R. L. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.04.006 · Cited by 1,514
Mitochondrial dysfunction: mechanisms and advances in therapy
Zong, Y., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,172
Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases
Ren, J., Bi, Y., Sowers, J. R., Hetz, C., & Zhang, Y. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00511-w · Cited by 708
Self-citation
Metadata
- Authors
- Ren, J., Pulakat, L., Whaley-Connell, A., & Sowers, J. R.
- Venue
- Journal of Molecular Medicine
- Published
- 2010-08-20
- Volume
- 88
- Issue
- 10
- Pages
- 993-1001
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W2037229939
- Cited by
- 367
- References
- 63
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.